| Line item | 2025-12-31 FY | 2024-12-31 FY | 2023-12-31 FY | 2022-12-31 FY | 2021-12-31 FY |
|---|---|---|---|---|---|
| Revenue | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Cost of Revenue | – | – | – | – | – |
| Gross Profit | – | – | – | – | – |
| Operating Expenses | $231.75M | $273.20M | $259.66M | $224.34M | $167.25M |
| R&D | $142.01M | $171.24M | $186.34M | $165.57M | $125.48M |
| SG&A | $86.50M | $101.96M | $73.32M | $58.77M | $41.77M |
| Operating Income | -$231.75M | -$273.20M | -$259.66M | -$224.34M | -$167.25M |
| Interest Expense | $1.89M | $1.89M | $1.88M | $1.86M | $2.98M |
| Tax Expense | $0.00 | $0.00 | $0.00 | – | – |
| Net Income | -$223.12M | -$258.75M | -$245.59M | -$221.86M | -$169.07M |
| EPS (basic) | -2.0100 | -2.7300 | -2.9200 | -3.2600 | -2.6700 |
| EPS (diluted) | -2.0100 | -2.7300 | -2.9200 | -3.2600 | -2.6700 |
| Shares (diluted) | $111.12M | $94.81M | $84.01M | $68.15M | $63.24M |